Filing Flows › Comparisons › LNAI vs HIND
Lunai Bioworks vs Vyome Holdings: LNAI and HIND compared
Lunai Bioworks is the larger company: $31K of revenue in its latest quarter (Q4 FY26) against $27K for Vyome Holdings (Q2 2026).
Where the money goes: LNAI and HIND
Lunai Bioworks (LNAI) · Q4 FY26
Lunai Bioworks, Q4 FY26: revenue $31K, net loss $2.0M, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
Vyome Holdings (HIND) · Q2 2026
Vyome Holdings, Q2 2026: revenue $27K (-46% year over year), net loss $720K, operating cash flow −$904K. The chart follows the revenue to costs, profit and cash.
| Lunai Bioworks (LNAI) | Vyome Holdings (HIND) | |
|---|---|---|
| Latest quarter | Q4 FY26 | Q2 2026 |
| Revenue | $31K | $27K |
| Revenue growth, Y/Y | — | -46% |
| Operating margin | n/m | n/m |
| Net earnings | −$2.0M | −$720K |
| Operating cash flow | −$1.8M | −$904K |
Questions
Which is bigger, Lunai Bioworks or Vyome Holdings?
Lunai Bioworks is the larger company: $31K of revenue in its latest quarter (Q4 FY26) against $27K for Vyome Holdings (Q2 2026).
More: Lunai Bioworks earnings · how Lunai Bioworks makes money · Vyome Holdings earnings · how Vyome Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-K filed Oct 13, 2026; 10-Q filed Aug 12, 2026). Fiscal quarters can end on different dates. Not investment advice.